Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
High Incidence of C797S Mutation in Patients With Long Treatment ...
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S ...
能够克服 EGFR 耐药突变 C797S 和 EGFR/ALK 共突变的候选药物 DA-0157 的发现和临床前评估,European ...
Monitoring epidermal growth factor receptor C797S mutation in Japanese ...
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung ...
The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor ...
Illustration of the Cis C797S and Trans C797S mutation and their ...
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation ...
Acquired EGFR C797S mediates resistance to AZD9291 in advanced non ...
Frequency of T790M loss and C797S acquisition among different EGFR ...
靶向 C797S 突变的新型 EGFR PROTAC 的设计、合成和生物学评估,Journal of Medicinal Chemistry ...
The Allelic Context of the C797S Mutation Acquired upon Treatment with ...
C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans ...
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced ...
EGFR C797S mutation mediates resistance to third-generation inhibitors ...
Real-world analysis of subsequent-line strategies for EGFR C797S mutant ...
Re-emerging C797S In Trans and Rechallenge of Osimertinib With ...
HSP90 inhibition overcomes CLN-081 resistance conferred by C797S ...
Full article: Fourth-generation EGFR-TKI to overcome C797S mutation ...
블루프린트, 2nd 'EGFR C797S 저해제' 공개.."올 임상" - 바이오스펙테이터
(PDF) C797S Mutation in Resistance Development to Third-Generation ...
Recombinant human EGFR (mutated C797S + L858R) protein (Active ...
(PDF) Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S ...
EGFR T790M C797S Reference Standard, mutation | GeneCopoeia™
LBx Probe EGFR C797S Multi┃理研ジェネシス
2,4-二胺烟酰胺衍生物作为靶向 C797S 突变的 EGFR 抑制剂的合成、活性及其关系,Bioorganic & Medicinal ...
Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated ...
Frontiers | Rational design of allosteric inhibitors targeting C797S ...
P3.12.26 Adding Gefitinib to Target Acquired C797S Mutation After ...
EGFR C797S 中 Lys745 磺酰化的机理模型揭示了抑制剂活性的化学决定因素并区分可逆剂和不可逆剂,Journal of ...
Insights into fourth generation selective inhibitors of (C797S) EGFR ...
EGFR Del19-T790M-C797S/BaF3_药靶模型_南京科佰生物科技有限公司
EGFR L858R-T790M-C797S/BaF3_药靶模型_南京科佰生物科技有限公司
Induction of T790M/C797S‐B‐specific CTL by the T790M/C797S‐B peptide ...
Frontiers | Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant ...
Growth Suppression in Lung Cancer Cells Harboring EGFR-C797S Mutation ...
Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase ...
刚明确奥希耐药？你需要了解这篇！→C797S突变：肺癌靶向治疗的“新壁垒” - 知乎
EGFR[C797S] - Tyrosine Kinase - ICE Bioscience - Protein platform
针对人类三重（Del19/T790M/C797S）突变的第四代EGFR抑制剂的设计与合成,European Journal of ...
EGFR-mutated lung cancers resistant to osimertinib through EGFR-C797S ...
In silico design of EGFRL858R/T790M/C797S inhibitors via 3D-QSAR ...
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer ...
EGFR L858R-C797S/BaF3_药靶模型_南京科佰生物科技有限公司
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor ...
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs ...
(PDF) Insights into fourth generation selective inhibitors of (C797S ...
EGFR (C797S), Active recombinant | Sigma-Aldrich
NCI-H1975-EGFR-KO-EGFR-L858R-C797S-Flag Cell Line - Kyinno Bio
EGFR Del19-T790M-C797S/PC14_药靶模型_南京科佰生物科技有限公司
A macrocyclic kinase inhibitor overcomes triple resistant mutations in ...
Longitudinal monitoring for the emergence of epidermal growth factor ...
Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M ...
Vanesa Gregorc, MD Melanoma, Thoracic Oncology, Head and Neck ...
LS-106是一种针对C797S的新型EGFR抑制剂，在体外和体内均表现出抗肿瘤活性,Cancer Science - X-MOL
Advanced lung adenocarcinoma harboring uncommon EGFR 19 Del and T790M ...
NCI-H1975-EGFR-T790M-C797S-L858R Cell Line - Kyinno Bio
NCI-H1975-EGFR-L858R-T790M-C797S-KI Cell Line
RMSD profile of triple mutant EGFR (L858R/T790M/C797S) protein complex ...
四代EGFR-TKI：攻克非小细胞肺癌C797S突变耐药挑战_bdtx-1535-CSDN博客
针对d746-750/T790M/C797S突变体的EGFR选择性抑制剂研发突破及挑战_生物器材网
EL-038 EGFR (D770_N771insSVD, C797S) BaF3 Stable Cell Line | Signosis
EL-037 EGFR (A767_dupASV, C797S) BaF3 Stable Cell Line | Signosis
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer ...
EGFR d746-750/C797S Recombinant Human Active Protein Kinase | EGFR d746 ...
EGFR[T790M/C797S] - Tyrosine Kinase - ICE Bioscience - Protein platform
EGFR L858R-T790M-C797S/NCI-H1975_药靶模型_南京科佰生物科技有限公司
Frontiers | Advanced lung adenocarcinoma harboring uncommon EGFR 19 Del ...
C797S耐药性：非小细胞肺癌中不可消灭的EGFR突变？,ACS Medicinal Chemistry Letters - X-MOL
EGFR[d746-750/T790M/C797S/L858R] - Tyrosine Kinase - ICE Bioscience ...
EGFR/C797S-IN-1 | TargetMol
Efficacy of immunotherapy targeting the neoantigen derived from ...
EGFR抑制剂研发的突破：针对d746-750/T790M/C797S突变体的选择性抑制
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective ...
第四代EGFR抑制剂WSD0922-FU：瞄准C797S耐药与脑转移的双重挑战 - 知乎
Functional analysis of the T790M/C797S‐B‐specific CTL clone. A ...
